STPT is currently developing a number of novel single- and combined-formulated products derived from traditional herbal medicines such as novel botanical drugs and functional dietary products. With our core competence, we have successfully established collaborations with multinational drug companies worldwide. Collaborations with multi-national drug companies include PhytoCeutica (USA) on PHY906 development that has entered Phase II clinical trials and Phytopharm (UK) on the development of PHYTOPICATM that has been approved and marketed for canine skin health. The existing domestic and international collaborations are listed as follows.

Current Domestic and Worldwide Collaborations and Strategic Alliances

• Sun Ten Pharmaceutical Co., Ltd., Taiwan
• Yung Shin Pharmaceuticals & Yung Zip Chemical Co., Ltd., Taiwan
• Advanced International Pharmaceutical Nanotech, Inc., Taiwan
• Panion & BF Biotech Inc., Taiwan
• PUMC Pharmaceuticals Co., Ltd., China
• Botanitex, US
• Phytopharm, UK
• Tzu Chi University College of Life Science
• Taipei Medical University - College of Medicine